Sign in
4

Changes in Ownership

Aardvark Therapeutics, Inc. Filed Acc 0000950170-25-086147

Options or other derivatives

  • Chief Executive Officer acquired 549,534 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lee Tien-Li · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-11 Grant or award : show line 1 in the form Stock option (right to buy) +549,534 549,534 D
Loading xslF345X05/ownership.xml…